Progressive Pulmonary Fibrosis Slows With Novel Agent

By News Health
4 hours Ago

(MedPage Today) — Novel oral agent nerandomilast slowed lung capacity decline in patients with non-idiopathic pulmonary fibrosis (IPF) interstitial lung disease (ILD) with a progressive pulmonary fibrosis phenotype, the phase III FIBRONEER-ILD…

Source link : https://www.medpagetoday.com/meetingcoverage/ats/115651

Author :

Publish date : 2025-05-19 16:17:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

New Dads, Non-Birthing Partners Less Likely to Get Prenatal Counseling on Vaccines

Novel Drug Reduced Bulging in Active and Chronic Thyroid Eye Disease

Senate Dems Urge HHS to Undo Rule Barring Some Public Comments

IG Live May 20: The Attack on Medicaid

Biden Has Reason for Optimism, Despite Advanced Prostate Cancer Diagnosis

The Price of Survival, Paid in Advance